Goldman Sachs’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101K | Buy |
130,198
+21,100
| +19% | +$16.3K | ﹤0.01% | 4880 |
|
|
2025
Q1 | $60K | Buy |
109,098
+7,700
| +8% | +$4.24K | ﹤0.01% | 4900 |
|
|
2024
Q4 | $92.7K | Buy |
101,398
+16,400
| +19% | +$15K | ﹤0.01% | 4790 |
|
|
2024
Q3 | $74K | Buy |
84,998
+1,400
| +2% | +$1.22K | ﹤0.01% | 4633 |
|
|
2024
Q2 | $82.8K | Hold |
83,598
| – | – | ﹤0.01% | 4516 |
|
|
2024
Q1 | $88.6K | Buy |
+83,598
| New | +$88.6K | ﹤0.01% | 4477 |
|
|
2021
Q2 | – | Sell |
-10,300
| Closed | -$39K | – | 5488 |
|
|
2021
Q1 | $39K | Buy |
+10,300
| New | +$39K | ﹤0.01% | 5160 |
|